BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17008788)

  • 1. Hemothorax following administration of intrapleural alteplase.
    Ruiz A; Porcel JM; Madroñero AB; Galindo C
    Respiration; 2006; 73(5):715. PubMed ID: 17008788
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
    Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
    Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural hemorrhage after administration of tPA: a case report and review of the literature.
    Goralski JL; Bromberg PA; Haithcock B
    Ther Adv Respir Dis; 2009 Dec; 3(6):295-300. PubMed ID: 19934281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural r-tPA in association with low-molecular heparin may cause massive hemothorax resulting in hypovolemia.
    Anevlavis S; Archontogeorgis K; Tzouvelekis A; Kouliatsis G; Pozova S; Bougioukas I; Bouros D; Froudarakis ME
    Respiration; 2011; 81(6):513-6. PubMed ID: 21063075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
    Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
    Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural alteplase in a patient with complicated pleural effusion.
    Walker CA; Shirk MB; Tschampel MM; Visconti JA
    Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural Alteplase and Dornase in a Pregnant Woman With Complicated Parapneumonic Effusion.
    Amariei DE; Tran BC; Yao R; Britt EM; Holden VK; Sachdeva A; Pickering EM
    Ann Thorac Surg; 2019 Nov; 108(5):e293-e294. PubMed ID: 30978314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
    Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
    J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural alteplase therapy: what are the knowns and unknowns?
    Staša J; Gregorová J; Pauk N
    Cas Lek Cesk; 2019; 158(7-8):295-299. PubMed ID: 31995996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
    Kemper P; Köhler D
    Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung white out: haemothorax after intrapleural tPA and DNase administration.
    Chong WH; Saha BK
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33371004
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.
    Merlo LG; Ansari S; Singh B; Teferedgin FF; Cervellione KL; Gintautas J; Babury MA
    Proc West Pharmacol Soc; 2009; 52():11-3. PubMed ID: 22128410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteplase beyond three hours in ischemic stroke: do we know enough?
    Jawaid A; Fitch O; Qureshi S; Wilson AM; Schulz PE
    Int J Stroke; 2009 Apr; 4(2):70. PubMed ID: 19383044
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrapleural Tissue Plasminogen Activator for Traumatic Retained Hemothorax.
    Holsen MR; Tameron AM; Evans DC; Thompson M
    Ann Pharmacother; 2019 Oct; 53(10):1060-1066. PubMed ID: 31007039
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion.
    Hamblin SE; Furmanek DL
    Pharmacotherapy; 2010 Aug; 30(8):855-62. PubMed ID: 20653362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use.
    Gilbert CR; Wilshire CL; Chang SC; Gorden JA
    Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy.
    Ben-Or S; Feins RH; Veeramachaneni NK; Haithcock BE
    Ann Thorac Surg; 2011 Mar; 91(3):860-3; discussion 863-4. PubMed ID: 21353015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions.
    Zuckerman DA; Reed MF; Howington JA; Moulton JS
    J Vasc Interv Radiol; 2009 Aug; 20(8):1066-9. PubMed ID: 19560940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraventricular tissue plasminogen activator toxicity.
    Gaberel T; Emery E
    Neurosurgery; 2011 Jan; 68(1):E288-9; author reply E289. PubMed ID: 21150745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.